Veidlapa Nr. M-3 (8)

Study Course Description

Nosaukums angliski

Main Study Course Information

Course Code

RKA_040

Branch of Science

Clinical medicine

ECTS

3.00

Target Audience

Medicine

LQF

Level 8

Study Course Implementer

Course Supervisor

Andris Skride

Residency Speciality

Speciality

Cardiologist

Supervisor of Medical Speciality

Andris Skride

Contacts

About Study Course

Objective

Ensure acquisition of theoretical knowledge and practical skills according to the most common small circulatory diseases, investigative methods and therapy for doctors of the cardiology specialty.

Learning Outcomes

Knowledge

1.• defines the hemodynamic criteria and classification of pulmonary hypertension; • knowledge of pulmonary hypertension aetiology, pathogenesis and risk factors; • describe the clinical manifestations of pulmonary hypertension and the progress of the disease; • knowledge of diagnostic algorithms, examination methods and differential diagnosis; • describe the treatment options for pulmonary arterial hypertension, groups of medicines and their mechanisms of action; • knowledge of the principles of risk stratification and patient monitoring; • is familiar with current clinical guidelines for the diagnosis and treatment of pulmonary hypertension.

Skills

1.• identify patients with possible pulmonary hypertension • interpret the results of echocardiography, laboratory, functional and imaging examinations; • evaluate indications for right cardiac catheterization; • differentiate between different groups of pulmonary hypertension • select appropriate diagnostic and treatment tactics; • assess the effectiveness of therapy and the risk of disease progression; • recognise signs of acute decompensation and initiate initial treatment.

Competences

1.• use an evidence-based approach in the care of patients with pulmonary hypertension; • cooperate with a multidisciplinary team in the diagnosis and treatment of patients; • provide the patient with understandable information about the disease, treatment and prognosis; • integrate current guidelines into clinical decision making.

Assessment

Individual work

Title	% from total grade	Grade
1. Studying literature	-	-

Examination

Title	% from total grade	Grade
1. Test	-	-
Examination of knowledge by study course - examination of theoretical knowledge (multi-answer test questions, open, theoretical questions)

Study Course Theme Plan

FULL-TIME

Part 1

Seminar

Modality	Location
On site	Study room

Topics

Pulmonary hypertension diagnostics, therapy

Seminar

Modality	Location
On site	Study room

Topics

Pulmonary artery thromboembolism - diagnosis, treatment

Seminar

Modality	Location
On site	Study room

Topics

COR pulmonale - Diagnostics, therapy

Total ECTS (Creditpoints):

3.00

Number of Residency Seminars:

Length (weeks):

Final Examination:

Residency exam (Theory and practice)

Bibliography

Required Reading

Humbert M et al: 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 43(38):3618-731, 2022 Simonneau G et al: Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 53(1):1801913, 2019

Hoeper MM et al: COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 60(1):2102311, 2022

Frost A et al: Diagnosis of pulmonary hypertension. Eur Respir J. 53(1):1801904, 2019

Klinger JR et al: Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest. 155(3):565-86, 2019

Morrell NW et al: Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 53(1):1801899, 2019

Sharma M et al: Revisiting a distinct entity in pulmonary vascular disease: chronic thromboembolic pulmonary hypertension (CTEPH). Medicina (Kaunas). 57(4):355, 2021

Konstantinides SV et al: 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 41(4):543-603, 2020

Moore C et al: Challenges and changes to the management of pulmonary embolism in the emergency department. Clin Chest Med. 39(3):539-47, 2018

Stevens SM et al: Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. ePub, 2021

10.

Sanz J., et al.: Anatomy, function, and dysfunction of the right ventricle . J Am Coll Cardiol 2019; 3 (12): pp. 1463-1482.

11.

Repessé X., et al.: Acute cor pulmonale in ARDS: rationale for protecting the right ventricle . Chest 2015; 147 (1): pp. 259-265

12.

Ghofrani H.A., et al.: Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease . Pulm Circ 2015; 5 (2): pp. 296-304